Skip to main content

Publications

featured publications

  • C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer.

    Journal for immunotherapy of cancer

    Authors: Niklas Klümper, Jonas Saal, Fiamma Berner, Christa Lichtensteiger, Nina Wyss, Annkristin Heine, Franz Georg Bauernfeind, Jörg Ellinger, Peter Brossart, Stefan Diem, Sabine Schmid, Markus Joerger, Martin Frueh, Manuel Ritter, Michael Hölzel, Lukas Flatz, Tobias Bald

  • Proliferative Potential, and Inflammatory Tumor Microenvironment in Meningioma Correlate with Neurological Function at Presentation and Anatomical Location-From Convexity to Skull Base and Spine.

    Cancers

    Authors: Johannes Wach, Tim Lampmann, Ági Güresir, Hartmut Vatter, Ulrich Herrlinger, Albert Becker, Silvia Cases-Cunillera, Michael Hölzel, Marieta Toma, Erdem Güresir

  • Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort.

    Urologia internationalis

    Authors: Benedikt Hoeh, Philipp Schmucker, Niklas Klümper, Oliver Hahn, Philip Zeuschner, Severine Banek, Pierre I Karakiewicz, Jörg Ellinger, Julia Heinzelbecker, Michael Hölzel, Arne Strauß, Friedemann Zengerling, Angelika Mattigk, Charis Kalogirou

  • CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor models.

    STAR protocols

    Authors: Maike Effern, Nicole Glodde, Emma Bawden, Jana Liebing, Daniel Hinze, Thomas Tüting, Thomas Gebhardt, Michael Hölzel

  • Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma.

    Journal of neuro-oncology

    Authors: Johannes Wach, Ági Güresir, Valeri Borger, Patrick Schuss, Albert Becker, Christoph Coch, Marie-Therese Schmitz, Michael Hölzel, Marieta Toma, Ulrich Herrlinger, Hartmut Vatter, Erdem Güresir

  • C-reactive protein flare-response predicts long-term efficacy to first-line anti-PD-1-based combination therapy in metastatic renal cell carcinoma.

    Clinical & translational immunology

    Authors: Niklas Klümper, Philipp Schmucker, Oliver Hahn, Benedikt Höh, Angelika Mattigk, Severine Banek, Jörg Ellinger, Julia Heinzelbecker, Danijel Sikic, Markus Eckstein, Arne Strauß, Friedemann Zengerling, Michael Hölzel, Philip Zeuschner, Charis Kalogirou

  • A pan-cancer fingerprint: common molecular denominators of the human tumor microenvironment.

    Signal transduction and targeted therapy

    Authors: Susanna S Ng, Sonia Leonardelli, Michael Hölzel

  • Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?

    Journal of clinical medicine

    Authors: Barbara Link, Adriana Torres Crigna, Michael Hölzel, Frank A Giordano, Olga Golubnitschaja

  • Combining FORGE Score and Histopathological Diagnostic Criteria of Atypical Meningioma Enables Risk Stratification of Tumor Progression.

    Diagnostics (Basel, Switzerland)

    Authors: Johannes Wach, Tim Lampmann, Ági Güresir, Hartmut Vatter, Albert J Becker, Michael Hölzel, Marieta Toma, Erdem Güresir

  • Molecular and Immune Correlates of PDCD1 (PD-1), PD-L1 (CD274), and PD-L2 (PDCD1LG2) DNA Methylation in Triple Negative Breast Cancer.

    Journal of immunotherapy (Hagerstown, Md. : 1997)

    Authors: Damian J Ralser, Niklas Klümper, Heidrun Gevensleben, Romina Zarbl, Christina Kaiser, Jennifer Landsberg, Michael Hölzel, Sebastian Strieth, Andree Faridi, Alina Abramian, Dimo Dietrich